Objective:
To present the surgical technique for subretinal placement of the PRIMA implant, an investigational therapy for advanced geographic atrophy.
Approach:
- Surgical Technique Overview: The PRIMA subretinal implant is designed for vision restoration in geographic atrophy (GA) by creating a subretinal bleb and inserting a photovoltaic implant that converts light into electrical signals.
- Surgical Procedure: The procedure involves vitrectomy, creating a retinotomy, and inserting the implant using a Flex Loop or soft-tip cannula, with careful management of the subretinal bleb.
Key Findings:
- The pivotal trial PRIMAvera showed significant vision improvement in patients with GA, as reported by Dr. Brodie.
- 80% of patients who were 20/400 or worse were able to read letters and numbers post-implantation, according to trial results.
- The implant consists of 378 individual photo cells and is designed to work with infrared goggles.
Interpretation:
Dr. Brodie suggested that the technology may have broader applications for other retinal atrophies, such as Stargardt disease and potentially retinitis pigmentosa.
Limitations:
- The study had instances of macular holes, indicating the need for careful preoperative planning, as noted in the trial.
- The technology requires intact inner retina anatomy for effective use, based on study findings.
Conclusion:
The PRIMA implant represents a novel approach to restoring vision in patients with geographic atrophy, as indicated by the PRIMA trial results, and may be applicable to other retinal diseases.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







